What You Should Know:
- Prenuvo, an Redwood City, CA-based advanced, radiation-free whole body imaging for early detection of cancer and other diseases raises $70M in Series A equity and debt funding led by Felicis, with participation from existing investors including Tony Fadell, NYT bestseller author and founder of Nest; Dr. Timothy A. Springer, Lasker award recipient; Anne Wojcicki, CEO of 23&Me; Steel Perlot, with Eric Schmidt as chairman; entrepreneur Rande Gerber; and wellness
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
Viome Raises $67M to Expand Microbiome & At-Home Test Kits
What You Should Know:
- Viome Life Sciences, a mission-driven digital health company, announced additional $67M in funding toward its Series C round.
- Led by Bold Capital Group, the $67M raise brings the company’s total funding to over $150M and will be used to support the development of its at-home tests that leverage precision nutrition to improve health and increase longevity by addressing the epidemic of chronic diseases, cancers, and aging.
- Viome will expand its proprietary mRNA
Read More
SURGE Therapeutics Raises $26M to Accelerate Intraoperative Immunotherapy
What You Should Know:
- SURGE Therapeutics (SURGE) recently announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute.
- The funds will be used to accelerate the development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel.
Using
Read More
Eclipse and Mayo Clinic Create Nucleus RadioPharma for Cancer Patients
What You Should Know:
- Eclipse, a venture capital firm investing in the digital transformation of the world's physical industries, and Mayo Clinic, a leading nonprofit health organization, recently announced the creation and seed funding of Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new
Read More
ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics
What You Should Know:
- ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The company will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. Its close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions it to research and develop
Read More
GRAIL, Carrum Health Partners to Help Employers Address Cancer Care
What You Should Know:
- GRAIL and Carrum Health announce a partnership to help self-insured employers improve care outcomes for their employees while also reigning in the rising cost of healthcare spending for this group: CANCER.
- This product integration will enable employers who offer Carrum Health benefits to provide eligible employees the Galleri test as part of the comprehensive cancer care Carrum delivers.
- Members who receive a signal detected from the Galleri test can work
Read More
Medical Gaslighting Remains Rampant for Women: Whose Job Is It To Stop It?
Have you ever gone to a medical appointment, knowing and feeling with certainty that something is wrong, only to have a doctor downplay and write off your symptoms?
Medical gaslighting, a relatively new, non-clinical term, refers to the practice of minimizing or dismissing a patient’s symptoms, concerns, or experiences. Often, symptoms are written off as psychological in nature, or patients are told that what they are experiencing isn’t serious or that it is normal.
The problem
Read More
Proscia Unveils New Enhancements to its Digital Pathology Platform
What You Should Know:
- Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows, which is CE-marked under IVDR.
- The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis. In doing so, they can realize the full promise of the shift away from microscope-based
Read More
Why It’s Time for Healthcare Organizations to Start Treating Patients Like Consumers
When the pandemic disrupted routine procedures and primary care across healthcare, many care delivery organizations believed patients would eventually return to in-person care as they always have once the pandemic was over and restrictions were lifted. Pent-up patient demand for non-emergency, preventative services–everything from cancer screenings to mental health support to birth control to smoking cessation–would eventually draw patients back into the healthcare system. Patients with common
Read More
Google Cloud Launches AI-Powered Medical Imaging Suite
What You Should Know:
- Google Cloud launches Medical Imaging Suite that addresses common pain points organizations face in developing artificial intelligence (AI) and machine learning models.
- Google Cloud enables the development of AI for imaging to support faster, more accurate diagnosis of images, increased productivity for healthcare workers, and improved care access and outcomes for patients.
Google Cloud's Medical Imaging Suite Key Features
Key features of the Medical
Read More
